Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3851 USD | -0.52% | -1.89% | -15.36% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Allen Baharaff
CEO | Chief Executive Officer | 59 | 99-12-31 |
Doron Cohen
DFI | Director of Finance/CFO | 57 | 22-01-31 |
Guy Nehemya
COO | Chief Operating Officer | 39 | 13-09-30 |
Liat Hayardeny
CTO | Chief Tech/Sci/R&D Officer | 57 | 16-09-06 |
Yohai Stenzler
AUD | Comptroller/Controller/Auditor | 41 | 14-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 14-05-31 |
Carol Brosgart
BRD | Director/Board Member | 72 | 17-06-06 |
Allen Baharaff
CEO | Chief Executive Officer | 59 | 99-12-31 |
Shmuel Nir
BRD | Director/Board Member | 62 | 06-12-31 |
Amir Poshinski
BRD | Director/Board Member | 63 | 20-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,009,654 | 5,777,152 ( 96.13 %) | 0 | 96.13 % |
Company contact information
Galmed Pharmaceuticals Ltd.
16 Abba Hillel Road
5250608, Ramat Gan
+972 3 693 8448
http://galmedpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.36% | 2.31M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.99% | 23.07B | |
-12.60% | 22.23B | |
-5.34% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- GLMD Stock
- Company Galmed Pharmaceuticals Ltd.